CHINA PHARMA HOLDINGS, INC. Payments for Construction in Process
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Payments for Construction in Process of -$310.25 thousand for the 9-month period ending 2015-09-30, per its 10-Q filed 2015-12-28.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForConstructionInProcess · last filed 2015-12-28
- CHINA PHARMA HOLDINGS, INC. payments for construction in process for the quarter ending 2015-09-30 was -$45.38K.
- CHINA PHARMA HOLDINGS, INC. payments for construction in process for the quarter ending 2015-06-30 was -$217.76K.
- CHINA PHARMA HOLDINGS, INC. payments for construction in process for the quarter ending 2015-03-31 was -$47.11K.
- CHINA PHARMA HOLDINGS, INC. payments for construction in process for the quarter ending 2014-09-30 was -$94.78K.
| Period end | Payments for Construction in Process 3 month | Payments for Construction in Process 6 month | Payments for Construction in Process 9 month |
|---|---|---|---|
| 2015-09-30 | -$45.38K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-12-28 | -$263.14K derived: sum of 2 quarters · filed 2015-12-28 | -$310.25K 10-Q · filed 2015-12-28 |
| 2015-06-30 | -$217.76K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-12-28 | -$264.87K 10-Q · filed 2015-12-28 | |
| 2015-03-31 | -$47.11K 10-Q · filed 2015-12-28 | ||
| 2014-09-30 | -$94.78K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-12-28 | -$884.60K derived: sum of 2 quarters · filed 2015-12-28 | -$4.64M 10-Q · filed 2015-12-28 |
| 2014-06-30 | -$789.82K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-12-28 | -$4.54M 10-Q · filed 2015-12-28 | |
| 2014-03-31 | -$3.75M 10-Q · filed 2015-12-28 | ||
| 2013-06-30 | -$49.03K 10-Q · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |